Fourth International Nanomedicine and Drug Delivery Symposium

描述（由申请人提供）：本申请是对NIH科学会议和科学会议支持（PA-06- 041）的回应。它旨在支持将于2006年10月8日至10日在奥马哈内布拉斯加大学医学中心举行的第四届年度纳米医学和药物输送研讨会。人们普遍认识到，需要发现和开发创新技术，以改善治疗和诊断药物在体内的输送。“下一代”疗法必须能够将药物、放射性核素、治疗性蛋白质和重组DNA输送到疾病的重点区域或肿瘤中，以最大限度地提高临床效益，同时限制不良副作用。利用纳米技术设计新的药物输送系统和装置是生物医学研究的一个快速发展的领域，有望在治疗和诊断方面取得突破性进展。本次会议的目的是提供一个论坛，让具有不同背景的科学家在纳米技术、细胞生物学、药物和基因传递、生物成像和临床转化研究方面讨论他们最新的研究成果。通过聚集具有不同背景但对使用纳米技术提供治疗和诊断药物有共同兴趣的基础和临床科学家和学员，这次会议将缩小这些研究界之间的差距。在最后的分析中，实现会议的目标将有助于开发用于诊断和治疗的新型纳米级递送技术，以解决未满足的临床需求。

DESCRIPTION (provided by applicant): This application is in response to the NIH Support for Scientific Conferences and Scientific Meetings (PA-06- 041). It is intended to support the Fourth Annual Nanomedicine and Drug Delivery Symposium to be held at the University of Nebraska Medical Center, in Omaha on October 8-10, 2006. The need for the discovery and development of innovative technologies to improve the delivery of therapeutic and diagnostic agents in the body is widely recognized. The "next generation" therapies must be able to deliver drugs, radionuclides, therapeutic proteins and recombinant DNA to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. The use of nanoscale technologies to design novel drug delivery systems and devices is a rapidly developing area of biomedical research that promises breakthrough advances in therapeutics and diagnostics. The objective of this conference is to provide a forum where scientists with diverse backgrounds specializing in nanotechnology, cellular biology, drug and gene delivery, bioimaging, and clinical translational research discuss the results of their latest investigations. By gathering basic and clinical scientists and trainees with diverse backgrounds but with the common interest in using nanotechnology in the delivery of therapeutic and diagnostic agents this conference will narrow the gap between these research communities. In the final analysis achieving the aim of the conference will contribute to the development of novel nanoscale delivery technologies for diagnostics and therapeutics that address unmet clinical needs.